NCT03490461View on ClinicalTrials.gov

Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

November 22, 2017

Primary Completion Date

March 1, 2018

Study Completion Date

March 1, 2018

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

Statin

Patients who used statins over 1 month for the treatment of dyslipidemia after LT were enrolled as statin group.

Trial Locations (1)

03722

Division of Endocrinology and Metabolism Department of Internal Medicine, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT03490461 - Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation | Biotech Hunter | Biotech Hunter